Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8559266 | 1.00 | PDK2 (0.32) | PDK2PDK4 | |
| SCHEMBL8554459 | 1.00 | PDK2 (0.32) | PDK2PDK4 | |
| Hydrochloric Acid SCHEMBL8557606 | 0.99 | PDK2 (0.32) | PDK2PDK4 | |
| SCHEMBL8556000 | 0.88 | PDK2 (0.32) | PDK2PDK4 | |
| SCHEMBL8558031 | 0.88 | PDK2 (0.32) | PDK2PDK4 | |
| SCHEMBL8555998 | 0.88 | PDK2 (0.32) | PDK2PDK4 | |
| SCHEMBL8554696 | 0.85 | PDK2 (0.31) | PDK2PDK4 | |
| SCHEMBL8558214 | 0.85 | PDK2 (0.31) | PDK2PDK4 | |
| SCHEMBL8554699 | 0.85 | PDK2 (0.31) | PDK2PDK4 | |
| SCHEMBL8558086 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1176960-B1 | SYNERGISTIC COMBINATION COMPRISING ROFLUMILAST AND A PDE-3 INHIBITOR | ALTANA PHARMA AG (DE) | 2004-09-29 | — | — | EP | claimed |
| JP-10204088-A | — | — | None | — | — | JP | disclosed |
| JP-H10204088-A | PRODUCTION OF INDOLE DERIVATIVE | KOWA CO | 1998-08-04 | — | — | JP | disclosed |
| EP-0653426-B1 | Indole derivatives, salts thereof and heart affection therapeutic agent comprising the same | KOWA CO (JP) | 1998-07-22 | — | — | EP | disclosed |
| US-5510366-A | INOTROPIC, ANTIARRHYMTHMIA AGENTS, VASODILATORS | KOWA CO., LTD. (JP) | 1996-04-23 | — | — | US | disclosed |
| EP-0653426-A1 | Indole derivatives, salts thereof and heart affection therapeutic agent comprising the same | KOWA COMPANY, LTD. (JP) | 1995-05-17 | — | — | EP | disclosed |